Koninklijke Philips Net Income 2010-2025 | PHG

Koninklijke Philips annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Koninklijke Philips net income for the quarter ending March 31, 2025 was $0.080B, a 111.22% decline year-over-year.
  • Koninklijke Philips net income for the twelve months ending March 31, 2025 was $0.843B, a 357.52% decline year-over-year.
  • Koninklijke Philips annual net income for 2024 was $-0.76B, a 50.62% increase from 2023.
  • Koninklijke Philips annual net income for 2023 was $-0.504B, a 70.23% decline from 2022.
  • Koninklijke Philips annual net income for 2022 was $-1.694B, a 143.15% decline from 2021.
Koninklijke Philips Annual Net Income
(Millions of US $)
2024 $-760
2023 $-504
2022 $-1,694
2021 $3,927
2020 $1,356
2019 $1,307
2018 $1,287
2017 $1,873
2016 $1,602
2015 $716
2014 $552
2013 $1,553
2012 $291
2011 $-1,798
2010 $1,928
2009 $591
Koninklijke Philips Quarterly Net Income
(Millions of US $)
2025-03-31 $80
2024-09-30 $199
2024-06-30 $486
2023-06-30 $79
2023-03-31 $-714
2022-06-30 $-23
2021-06-30 $181
2020-06-30 $229
2019-06-30 $273
2018-06-30 $1
2017-06-30 $275
2016-12-31 $680
2016-09-30 $413
2016-06-30 $475
2016-03-31 $35
2015-12-31 $-51
2015-09-30 $355
2015-06-30 $301
2015-03-31 $112
2014-12-31 $169
2014-09-30 $-138
2014-06-30 $332
2014-03-31 $189
2013-12-31 $553
2013-09-30 $374
2013-06-30 $414
2013-03-31 $213
2012-12-31 $-482
2012-09-30 $221
2012-06-30 $204
2012-03-31 $326
2011-12-31 $-212
2011-09-30 $102
2011-06-30 $-1,934
2011-03-31 $198
2010-12-31 $630
2010-09-30 $676
2010-06-30 $331
2010-03-31 $277
2009-12-31 $384
2009-09-30 $254
2009-06-30 $64
2009-03-31 $-75
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.033B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $239.054B 28.75
Boston Scientific (BSX) United States $154.291B 38.63
Stryker (SYK) United States $149.710B 31.30
EssilorLuxottica (ESLOY) France $128.407B 0.00
Medtronic (MDT) Ireland $110.260B 15.63
Lonza Group Ag (LZAGY) Switzerland $50.622B 0.00
Haleon (HLN) United Kingdom $47.216B 26.92
ResMed (RMD) United States $37.817B 28.40
Agilent Technologies (A) United States $33.696B 21.97
GE HealthCare Technologies (GEHC) United States $33.311B 15.81
Terumo (TRUMY) Japan $27.198B 35.33
Insulet (PODD) United States $21.551B 84.59
Zimmer Biomet Holdings (ZBH) United States $18.358B 11.79
Baxter (BAX) United States $15.708B 11.73
Smith & Nephew SNATS (SNN) United Kingdom $13.095B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.558B 22.82
Lantheus Holdings (LNTH) United States $5.573B 14.06
Prestige Consumer Healthcare (PBH) United States $4.039B 18.04
Perrigo (PRGO) Ireland $3.660B 9.28
Haemonetics (HAE) United States $3.526B 16.06
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.280B 27.25
ICU Medical (ICUI) United States $3.251B 23.97
GN Store Nord (GNNDY) Denmark $2.346B 19.43
LeMaitre Vascular (LMAT) United States $1.910B 42.70
QuidelOrtho (QDEL) United States $1.901B 13.07
AtriCure (ATRC) United States $1.598B 0.00
Acuren (TIC) United States $1.263B 0.00
AdaptHealth (AHCO) United States $1.216B 12.34
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Neogen (NEOG) United States $1.057B 13.53
BioLife Solutions (BLFS) United States $1.015B 0.00
Phibro Animal Health (PAHC) United States $1.003B 12.82
Kestra Medical Technologies (KMTS) United States $0.908B 0.00
InMode (INMD) Israel $0.898B 9.05
CeriBell (CBLL) United States $0.698B 0.00
Owens & Minor (OMI) United States $0.607B 5.04
Evolus (EOLS) United States $0.587B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.578B 0.00
Curaleaf Holdings (CURLF) Canada $0.557B 0.00
Valneva SE (VALN) France $0.468B 0.00
Capricor Therapeutics (CAPR) United States $0.459B 0.00
Surmodics (SRDX) United States $0.413B 0.00
Tilray Brands (TLRY) Canada $0.396B 0.00
VAREX IMAGING (VREX) United States $0.335B 12.32
SNDL (SNDL) Canada $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Sanuwave Health (SNWV) United States $0.281B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.250B 0.00
ZimVie (ZIMV) United States $0.250B 11.34
Sanara MedTech (SMTI) United States $0.249B 0.00
Quanterix (QTRX) United States $0.241B 0.00
Brainsway (BWAY) Israel $0.233B 61.65
Biote (BTMD) United States $0.227B 6.37
Canopy Growth (CGC) Canada $0.226B 0.00
Aurora Cannabis (ACB) Canada $0.220B 65.33
OraSure Technologies (OSUR) United States $0.215B 0.00
Omeros (OMER) United States $0.205B 0.00
TriSalus Life Sciences (TLSI) United States $0.197B 0.00
Utah Medical Products (UTMD) United States $0.181B 14.71
High Tide (HITI) Canada $0.178B 0.00
Organigram Global (OGI) Canada $0.177B 0.00
Verano Holdings (VRNOF) United States $0.175B 0.00
Exagen (XGN) United States $0.144B 0.00
Vireo Growth (VREOF) United States $0.138B 0.00
FitLife Brands (FTLF) United States $0.120B 14.81
Jin Medical (ZJYL) China $0.108B 0.00
Veru (VERU) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Fonar (FONR) United States $0.088B 11.32
Quipt Home Medical (QIPT) United States $0.084B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
TerrAscend (TSNDF) Canada $0.078B 0.00
Cytosorbents (CTSO) United States $0.075B 0.00
Zynex (ZYXI) United States $0.074B 0.00
Apyx Medical (APYX) United States $0.072B 0.00
InterCure (INCR) Israel $0.067B 0.00
Agape ATP (ATPC) $0.063B 0.00
Jushi Holdings (JUSHF) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
Nephros (NEPH) United States $0.045B 59.98
Modular Medical (MODD) United States $0.044B 0.00
United-Guardian (UG) United States $0.038B 13.25
Rockwell Medical (RMTI) United States $0.028B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Senestech (SNES) United States $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00